The Commission has established, through the analysis of a sufficiently representative sample of public procurement procedures in the PRC [The sample is composed of the 35504 tenders that contained in a publicly available format the minimum documents that allow to determine the eligibility criteria and other conditions of participation for prospective bidders and could thus be usefully examined for the purpose of the investigation (see Section 2.3, recital 51 of the SWD).], that 87 % of the public tenders for medical devices contain explicit and/or implicit prohibitions to procure imported medical devices or discriminatory requirements affecting such procurement [See Section V of the investigation report, p. 10 and Section 2.3.1, recital 54 of the SWD.]. The examination of those tenders showed that the prohibitions and discriminations apply irrespective of the value of the contract. As established in the staff working document accompanying the investigation report, the fact that the purchase of imported medical devices may be allowed in a tender procedure does not necessarily mean that imported medical devices are not subject to discrimination, for instance through technology transfer requirements [‘In fact, discrimination affects the procurement of imported medical devices even if such procurement is approved, to the extent that Article 5 of the Administrative Measures instructs procuring entities to “give priority to purchasing products that transfer technology […], provide training services and other compensation trade measures”’ (see Section 2.3, recital 55 of the SWD).]. Furthermore, even in the cases where the procurement of imported medical devices is authorised, the sectorial targets referred to in recital 17 for domestic procurement create a significant advantage for those suppliers and medical devices originating in the PRC. Therefore, the Commission has established that the overarching system of generally applicable preferences for the procurement of domestic medical devices in the PRC, which consists in laws and implementing measures of general application, affects the entire public procurement market for medical devices in the PRC irrespective of the value of the procurement contract. Thus the Commission concluded in its investigation report that these measures and practices result in a serious and recurrent impairment of access of Union economic operators and Union-made medical devices to the public procurement market for medical devices in the PRC.
19 2. DETERMINATION OF THE IPI MEASURE › 2.1. Proportionality and adequacy of a possible IPI measure with regard to the identified measures and practices › 2.1.1. The identified measures and practices, Regulation (EU) 2025/1197
In forcesince 19 Jun 2025